ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Access to Guideline Concordant Care for Node-Positive Non-Small Cell Lung Cancer in the United States

Thursday, March 14, 2024

Submitted by

Jo Chikwe

Source

Source Name: The Annals of Thoracic Surgery

Source URL: https://www.annalsthoracicsurgery.org/article/S0003-4975(23)01165-7/abstract

Author(s)

Micaela L. Collins, Shale J. Mack, Gregory L. Whitehorn, Brian M. Till, Tyler R. Grenda, Nathaniel R. Evans III, Sarah W. Gordon, Olugbenga T. Okusanya

To assess whether seeking care at multiple Commission on Cancer hospitals is associated with different rates of guideline-concordant care, 44,531 patients undergoing treatment for non-small cell lung cancer between 2004 and 2018 were analyzed. Visiting more than one Commission on Cancer hospital was associated with higher rates of guideline-concordant care for individuals with pN1 to pN2 lung cancer and higher overall survival at five years (54.35 percent vs 45.62 percent, P < .001).